Search Results 1051-1060 of 19848 for Hepatitis b

  1. A Study to Evaluate the Effectiveness and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis - Mayo Clinic

    Chronic hepatitis B virus infection: positive for hepatitis B surface antigen (HBsAg) or hepatitis B core antibody; or; Chronic hepatitis C virus (HCV) ...

  2. A Study to Test Nivolumab with Usual Chemotherapy Treatment or Usual Chemotherapy Treatment Alone to Treat Recurrent or Metastatic Nasopharyngeal Cancer - Mayo Clinic

    Patients who are immune to hepatitis B (anti-Hepatitis B surface antibody positive) are eligible (i.e., patients immunized against hepatitis B). In some ...

  3. Nausea and vomiting - Mayo Clinic

    Hepatitis B and Hepatitis C: What's the difference? Hepatitis C · Hepatitis C screening · Hepatitis C: How common is sexual transmission? Hepatitis C: What ...

  4. Adalimumab (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Granulomatosis polyangiitis—Use with caution. May increase the chance of getting new cancers. Diabetes or; Hepatitis B, history of or; Opportunistic infections, ...

  5. A Platform Study In Non-Small Cell Lung Cancer (NSCLC) - Mayo Clinic

    * Known active hepatitis A. * Acute hepatitis B infection (anti-hepatitis B core antibody \[HBc\] immunoglobulin M \[IgM\] positive) or chronic hepatitis B ...

  6. TMJ disorders - Doctors and departments - Mayo Clinic

    Transplant Hepatologist. Phoenix, AZ. Areas of focus: Nonalcoholic fatty liver disease, Cirrhosis, Hepatitis C, Hepatitis B, Alcoholic hepatitis, Viral ...

  7. A Study To Evaluate The Effectiveness And Safety Of Obeticholic Acid To Treat Patients With Primary Sclerosing Cholangitis - Mayo Clinic

    Current Child Pugh classification B or C; History of liver ... Hepatitis B virus (unless seroconverted and no positive Hepatitis B Virus DNA) ...

  8. General Internal Medicine - Doctors - Mayo Clinic

    Horsley, M.D.. Internist. Phoenix, AZ. Areas of focus: LGBT health care, Sexual dysfunction, Hepatitis C, Hepatitis B, HIV/AIDS, Erectile dysfunction, Sexually ...

  9. Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

    Serologic status reflecting active hepatitis B or C infection; patients that are positive for hepatitis B core antibody, hepatitis B surface antigen (HBsAg) ...

  10. Study to Assess the Effectiveness and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone to Treat Patients with Previously Treated Non-Hodgkins Lymphoma - Mayo Clinic

    ... B‐Cell Lymphoma patients. Participation eligibility. Participant ... Evidence of chronic active Hepatitis B (HBV) as evidenced by a detectable hepatitis ...